← Open Payments lookup

THOMAS OKRASINSKI: Open Payments

NPI 1700252095 · EVANSTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$430 in 13 payments from 10 companies in 2025. Trend: 2023 $415 · 2024 $531 · 2025 $430

Food & beverage: $430
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation2$148
Bayer Healthcare Pharmaceuticals Inc.2$64
Otsuka America Pharmaceutical, Inc.2$44
AstraZeneca Pharmaceuticals LP1$29
Boehringer Ingelheim Pharmaceuticals, Inc.1$27
Alexion Pharmaceuticals, Inc.1$27
Calliditas Therapeutics US Inc.1$25
Mallinckrodt Hospital Products Inc.1$25
Novo Nordisk Inc1$21
Ardelyx, Inc.1$20

Products named: Fabhalta, Kerendia, FARXIGA, JARDIANCE, ULTOMIRIS, TARPEYO, ACTHAR, JYNARQUE.

Industry payments across IL — which companies pay providers there.